Breathing and qigong: a drug-free approach to easier breathing for damaged lungs?
NCT ID NCT07725991
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial tests whether combining resonant breathing (slow, paced breathing) with Qigong exercises can improve lung function, reduce shortness of breath, and boost quality of life in adults aged 40–65 with bronchiectasis, a chronic lung condition. Participants are randomly assigned to either resonant breathing alone or resonant breathing plus Qigong for three weeks. The study measures changes in lung function, breathlessness, and quality of life using standard questionnaires and spirometry.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Resonant breathing and Qigong exercises
- What this could lead to
- If effective, this combination of breathing techniques and gentle movement could offer a low-cost, drug-free way to improve breathing and daily life for people with bronchiectasis.
- What could go wrong
- This is a small, early-stage trial with only 46 participants over 3 weeks, so results may not apply broadly. The exercises require regular participation and may not help everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
46 people
The number who actually took part.
- Started
-
Dec 2025
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 40 to 65 years * Both male and female participants * Diagnosed with bronchiectasis confirmed by clinical and radiological findings * Clinically stable for at least 4 weeks (no acute exacerbation) * Willing and able to participate in breathing and/or Qigong exercise sessions regularly for 3 weeks Exclusion Criteria: * Individuals who have experienced a recent flare-up of bronchiectasis in the last month. * Patients with serious heart, muscle, or nerve disorders that restrict movement * Participants already enrolled in other respiratory therapy programs. * Those with mental or communication difficulties preventing proper participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchiectasis adult are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Riphah International University
Sheikhupura, Punjab Province, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mapping patient profiles unlock better breathing therapy for bronchiectasis?
- Can an inhaled drug ease bronchiectasis? a trial seeks answers
- Could your own lung cells heal damaged airways? a new trial aims to find out
- New drug CTX-187 takes aim at stubborn bacterial infections
- Lung patients may soon do rehab from home via app
- New study aims to find best exercise test for lung disease patients